Apixaban, Treatment of Deep Vein Thrombosis and-or Pulmonary Embolism


exp date isn't null, but text field is


Apixaban is an oral anticoagulant that has been approved for the treatment and secondary prevention of acute deep vein thrombosis (DVT) and/or pulmonary embolism (PE). The following provides guidance as to which patients can be considered for this drug treatment.


Use the button below to access this resource item.

Access this resource

Last reviewed: 08 October 2018

Next review: 31 October 2020

Author(s): Campbell Tait

Version: 2

Approved By: Medicines Utilisation Subcommittee of ADTC

Document Id: 393